Jeffrey Edward Nelson serves as Chief Operating Officer at Milestone Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Edward Nelson has executed 6 insider transactions totaling $158.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 26, 2026 involved exercising options for 20,100 shares valued at $0.
Jeffrey Edward Nelson currently holds 60,300 shares of Milestone Pharmaceuticals Inc. (MIST), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Jeffrey Edward Nelson has been a net seller of MIST stock. They have purchased $0 and sold $158.2K worth of shares.
Jeffrey Edward Nelson's most recent insider trade was on Jan 26, 2026, when they sold 20,100 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.93 |
| Discretionary |
| Jan 26, 2026 | MIST | $0 | Option Exercise | 20,100 | $N/A | Discretionary |
| Dec 15, 2025 | MIST | $134.6K | Sale | 58,007 | $2.32 | Discretionary |
| Dec 12, 2025 | MIST | $0 | Award | 100,000 | $N/A | Discretionary |
| Dec 12, 2025 | MIST | $0 | Award | 100,000 | $N/A | Discretionary |